查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1279776

2022-2029年全球骨关节炎治疗药物市场规模研究与预测，按药物类型分析，按分销渠道和区域分析

Global Osteoarthritis Therapeutics Market Size study & Forecast, by Anatomy by Drug Type, by Distribution Channel and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

2021年全球骨关节炎治疗药物市场价值约为7.34846亿美元，预计在2022-2029年预测期内将以超过8.8%的健康增长率增长。作为最普遍的慢性健康疾病之一，骨关节炎的特点是持续的疼痛、损伤和活动能力下降。它是一种关节的退行性病变，随着时间的推移而恶化，是由一个或多个关节的软骨退化和最终丧失带来的。软骨的一个例子是存在于骨骼之间的关节，包括膝关节、踝关节和肘关节。它有助于润滑关节和降低摩擦。骨关节炎的治疗旨在减少疼痛和改善功能状态。由于骨关节炎的发病率越来越高，以及易受骨关节炎影响的人口越来越多等因素，骨关节炎治疗市场正在扩大。

根据美国疾病控制和预防中心的数据，在2020年，美国约有6300万人被诊断患有关节炎，预计到2045年将达到7800万人。因此，骨关节炎发病率的上升正在推动市场的增长。欧洲临床医学杂志》在2020年指出，全世界40岁以上的人中大约有22%被诊断为膝关节骨性关节炎。根据世界银行集团的数据，2020年世界老龄人口为7.27亿，预计在未来30年将增加三倍，在2050年达到15亿。因此，该地区老年人口的增加进一步推动了市场的增长。此外，运动损伤数量的增加和治疗骨关节炎的个性化药物的开发正在为市场创造一个有利的增长。然而，在骨关节炎治疗中使用非甾体抗炎药的不良心血管事件风险和替代品的商业化可能会阻碍市场增长。

全球骨关节炎治疗药物市场研究考虑的主要地区包括亚太地区、北美、欧洲、拉丁美洲和世界其他地区。由于主要市场参与者的主导地位和该地区日益增长的疾病流行率，北美在收入方面主导了市场。而亚太地区在预测期内预计将以最高的复合年增长率增长，原因是老年病和目标人群的增加，产品开发合作的数量增加，主要参与者的地理扩张，以及政府和非营利组织对市场空间的积极参与等因素。

该研究的目的是确定近年来不同领域和国家的市场规模，并预测未来几年的价值。该报告旨在将研究涉及的国家内的行业的质量和数量方面都纳入其中。

该报告还提供了关于关键方面的详细信息，如驱动因素和挑战，这将确定市场的未来增长。此外，它还纳入了微观市场的潜在机会，供利益相关者投资，以及对竞争格局和主要参与者的分析产品的详细分析。.

目录

第一章：执行摘要

  • 市场简介
  • 2019-2029年全球及细分市场的估计和预测
    • 2019-2029年，按地区分類的骨关节炎治疗剂市场
    • 2019-2029年骨关节炎治疗法市场，按解剖学划分
    • 2019-2029年，按药物类型划分，骨关节炎治疗市场
    • 2019-2029年，按分销渠道划分，骨关节炎治疗市场
  • 主要趋势
  • 估算方法
  • 研究假设

第二章：全球骨关节炎治疗药物市场的定义和范围

  • 本研究的目的
  • 市场定义和范围
    • 研究的范围
    • 行业演变
  • 研究考虑的年份
  • 货币兑换率

第三章：全球骨关节炎治疗剂市场动态

  • 骨关节炎治疗剂市场影响分析（2019-2029年）
    • 市场驱动力
      • 骨关节炎的发病率不断增加
      • 易受骨关节炎影响的人口不断增加
    • 市场挑战
      • 与使用非甾体抗炎药有关的不良心血管事件的风险
      • 替代品的商业化
    • 市场机会
      • 运动伤害的数量不断增加
      • 个人化药物的开发

第四章：全球骨关节炎治疗药物市场行业分析

  • 波特五力模型
    • 供应商的议价能力
    • 买方的讨价还价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争性的竞争
  • 波特五力模型的未来方法（2019-2029年）
  • PEST分析
    • 政治因素
    • 经济
    • 社会
    • 技术
  • 最佳投资机会
  • 最佳策略
  • 行业专家展望
  • 分析师建议和结论

第五章：风险评估：COVID-19的影响

  • 评估COVID-19对行业的整体影响
  • COVID-19前和COVID-19后的市场情况

第六章：全球骨关节炎治疗药物市场，按解剖学分类

  • 市场简介
  • 全球骨关节炎治疗剂市场，按解剖学分类，性能-潜力分析
  • 2019-2029年全球骨关节炎治疗剂市场按解剖学的估计和预测
  • 骨关节炎治疗剂市场，細項分析
    • 膝关节骨性关节炎
    • 髋关节骨关节炎
    • 手部骨关节炎
    • 小关节骨关节炎

第7章 ：全球骨关节炎治疗药物市场，按药物类型划分

  • 市场简介
  • 按药物类型分類的全球骨关节炎治疗剂市场，表现 - 潜力分析
  • 2019-2029年全球骨关节炎治疗剂市场按药物类型的估计和预测
  • 骨关节炎治疗剂市场，細項分析
    • 粘液补充剂
    • 非甾体类抗炎药
    • 镇痛剂
    • 皮质类固醇

第八章：全球骨关节炎治疗药物市场，按分销渠道划分

  • 市场简介
  • 按分销渠道分類的全球骨关节炎治疗剂市场，表现 - 潜力分析
  • 2019-2029年全球骨关节炎治疗剂市场按分销渠道的估计和预测
  • 骨关节炎治疗剂市场，細項分析
    • 医院药房
    • 零售药店
    • 网上药店

第九章：全球骨关节炎治疗药物市场，区域分析

  • 骨关节炎治疗药物市场，区域市场简介
  • 北美洲
    • 美国
      • 2019-2029年解剖学分类估计和预测
      • 2019-2029年药物类型细分估计和预测
      • 2019-2029年，分销渠道的细分估计和预测
    • 加拿大
  • 欧洲骨关节炎治疗药物市场简介
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 欧洲其他地区
  • 亚太地区骨关节炎治疗药物市场简介
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 亚太其他地区
  • 拉丁美洲骨关节炎治疗药物市场简介
    • 巴西
    • 墨西哥
    • 拉美其他地区
  • 世界其他地区

第十章：竞争情报

  • 顶级市场战略
  • 公司简介
    • Pfizer, Inc
      • 关键信息
      • 概况
      • 财务（取决于数据的可用性）
      • 产品摘要
      • 近期发展情况
    • Eli Lilly and Company
    • Horizon Therapeutics plc
    • Ferring B.V.
    • Merck Sharp & Dohme Corp.
    • GlaxoSmithKline Plc.
    • Johnson & Johnson Private Limited
    • Bayer AG
    • Novartis AG
    • Pacira Pharmaceuticals, Inc

第十一章 ：研究过程

  • 研究过程
    • 资料探勘
    • 分析
    • 市场评估
    • 验证
    • 出版
  • 研究属性
  • 研究假设

Global Osteoarthritis Therapeutics Market is valued approximately USD 7348.46 million in 2021 and is anticipated to grow with a healthy growth rate of more than 8.8% over the forecast period 2022-2029. One of the most prevalent chronic health disorders, osteoarthritis is characterised by persistent pain, impairment, and decreased mobility. It is a degenerative condition of the joints that worsens with time and is brought on by the deterioration and eventual loss of cartilage in one or more joints. An example of cartilage is present in the joints between bones include the knee, ankle, and elbow. It assists in lubricating the joint and lowering friction. Treatment for osteoarthritis aims to reduce pain and improve functional status. The Osteoarthritis Therapeutics market is expanding because of factors such as Increasing prevalence of osteoarthritis and Growing population susceptible to osteoarthritis.

According to Centers for Disease Control and Prevention, in year 2020, there were around 63 million people in US had diagnosed with arthritis which is expected to reach at 78 million by year 2045. Thus rising prevelance of osteoarthritis is propelling the market growth. The Journal of EClinical Medicine stated in 2020 that roughly 22% of people over 40 years of age worldwide have been diagnosed with knee osteoarthritis. According to the World Bank Group, the world old population was 727 million in 2020, and it is predicted to treble over the next three decades, reaching 1.5 billion in 2050. Thus rising geriatric population in the region is further escalating the market growth. In addition, Rising number of sports injuries and development of Personalized medicines for osteoarthritis is creating a lucrative growth to the market. However, Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment and Commercialization of alternatives may hamper the market growth.

The key regions considered for the Global Osteoarthritis Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of key market players and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market players included in this report are:

  • Pfizer, Inc
  • Eli Lilly and Company
  • Horizon Therapeutics plc
  • Ferring B.V.
  • Merck Sharp & Dohme Corp.
  • GlaxoSmithKline Plc.
  • Johnson & Johnson Private Limited
  • Bayer AG
  • Novartis AG
  • Pacira Pharmaceuticals, Inc

Recent Developments in the Market:

  • In January 2023, Arugula Sciences, LLC announced that it had received FDA permission for a Phase 1 clinical trial in the US for its first therapeutic product, Signature Cord PrimeTM. This was accomplished in partnership with its clinical partners. For patients with symptomatic knee osteoarthritis, this Phase 1 research is an open-label, dosage-ranging evaluation of safety, tolerability, preliminary effectiveness, and dose effects.
  • In February 2022, Alkem Laboratories announced that the Drug Controller General of India (DCGI) had approved the marketing of StemOne in India. The product is suggested for a variety of conditions, including knee osteoarthritis. It is the first allogeneic cell therapy product to be given commercial approval in India for the treatment of osteoarthritis of the knee.

Global Osteoarthritis Therapeutics Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Anatomy, Drug Type, Distribution Channel, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Anatomy offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Anatomy:

  • Knee Osteoarthritis
  • Hip Osteoarthritis
  • Hand Osteoarthritis
  • Small Joint Osteoarthritis

By Drug Type:

  • Viscosupplementation Agents
  • Non-steroidal Anti-inflammatory Drugs
  • Analgesics
  • Corticosteroids

By Distribution Channel:

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
    • 1.2.1. Osteoarthritis Therapeutics Market, by Region, 2019-2029 (USD Million)
    • 1.2.2. Osteoarthritis Therapeutics Market, by Anatomy , 2019-2029 (USD Million)
    • 1.2.3. Osteoarthritis Therapeutics Market, by Drug Type, 2019-2029 (USD Million)
    • 1.2.4. Osteoarthritis Therapeutics Market, by Distribution Channel, 2019-2029 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Osteoarthritis Therapeutics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Osteoarthritis Therapeutics Market Dynamics

  • 3.1. Osteoarthritis Therapeutics Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevalence of osteoarthritis
      • 3.1.1.2. Growing population susceptible to osteoarthritis
    • 3.1.2. Market Challenges
      • 3.1.2.1. Risk of adverse cardiovascular events associated with the use of NSAIDs
      • 3.1.2.2. Commercialization of alternatives
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising number of sports injuries
      • 3.1.3.2. Development of Personalized medicines

Chapter 4. Global Osteoarthritis Therapeutics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Osteoarthritis Therapeutics Market, by Anatomy

  • 6.1. Market Snapshot
  • 6.2. Global Osteoarthritis Therapeutics Market by Anatomy , Performance - Potential Analysis
  • 6.3. Global Osteoarthritis Therapeutics Market Estimates & Forecasts by Anatomy 2019-2029 (USD Million)
  • 6.4. Osteoarthritis Therapeutics Market, Sub Segment Analysis
    • 6.4.1. Knee Osteoarthritis
    • 6.4.2. Hip Osteoarthritis
    • 6.4.3. Hand Osteoarthritis
    • 6.4.4. Small Joint Osteoarthritis

Chapter 7. Global Osteoarthritis Therapeutics Market, by Drug Type

  • 7.1. Market Snapshot
  • 7.2. Global Osteoarthritis Therapeutics Market by Drug Type, Performance - Potential Analysis
  • 7.3. Global Osteoarthritis Therapeutics Market Estimates & Forecasts by Drug Type 2019-2029 (USD Million)
  • 7.4. Osteoarthritis Therapeutics Market, Sub Segment Analysis
    • 7.4.1. Viscosupplementation Agents
    • 7.4.2. Non-steroidal Anti-inflammatory Drugs
    • 7.4.3. Analgesics
    • 7.4.4. Corticosteroids

Chapter 8. Global Osteoarthritis Therapeutics Market, by Distribution Channel

  • 8.1. Market Snapshot
  • 8.2. Global Osteoarthritis Therapeutics Market by Distribution Channel, Performance - Potential Analysis
  • 8.3. Global Osteoarthritis Therapeutics Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Million)
  • 8.4. Osteoarthritis Therapeutics Market, Sub Segment Analysis
    • 8.4.1. Hospitals Pharmacies
    • 8.4.2. Retail Pharmacies
    • 8.4.3. Online Pharmacies

Chapter 9. Global Osteoarthritis Therapeutics Market, Regional Analysis

  • 9.1. Osteoarthritis Therapeutics Market, Regional Market Snapshot
  • 9.2. North America Osteoarthritis Therapeutics Market
    • 9.2.1. U.S. Osteoarthritis Therapeutics Market
      • 9.2.1.1. Anatomy breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Drug Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Osteoarthritis Therapeutics Market
  • 9.3. Europe Osteoarthritis Therapeutics Market Snapshot
    • 9.3.1. U.K. Osteoarthritis Therapeutics Market
    • 9.3.2. Germany Osteoarthritis Therapeutics Market
    • 9.3.3. France Osteoarthritis Therapeutics Market
    • 9.3.4. Spain Osteoarthritis Therapeutics Market
    • 9.3.5. Italy Osteoarthritis Therapeutics Market
    • 9.3.6. Rest of Europe Osteoarthritis Therapeutics Market
  • 9.4. Asia-Pacific Osteoarthritis Therapeutics Market Snapshot
    • 9.4.1. China Osteoarthritis Therapeutics Market
    • 9.4.2. India Osteoarthritis Therapeutics Market
    • 9.4.3. Japan Osteoarthritis Therapeutics Market
    • 9.4.4. Australia Osteoarthritis Therapeutics Market
    • 9.4.5. South Korea Osteoarthritis Therapeutics Market
    • 9.4.6. Rest of Asia Pacific Osteoarthritis Therapeutics Market
  • 9.5. Latin America Osteoarthritis Therapeutics Market Snapshot
    • 9.5.1. Brazil Osteoarthritis Therapeutics Market
    • 9.5.2. Mexico Osteoarthritis Therapeutics Market
    • 9.5.3. Rest of Latin America Osteoarthritis Therapeutics Market
  • 9.6. Rest of The World Osteoarthritis Therapeutics Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Pfizer, Inc
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Eli Lilly and Company
    • 10.2.3. Horizon Therapeutics plc
    • 10.2.4. Ferring B.V.
    • 10.2.5. Merck Sharp & Dohme Corp.
    • 10.2.6. GlaxoSmithKline Plc.
    • 10.2.7. Johnson & Johnson Private Limited
    • 10.2.8. Bayer AG
    • 10.2.9. Novartis AG
    • 10.2.10. Pacira Pharmaceuticals, Inc

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Osteoarthritis Therapeutics Market, report scope
  • TABLE 2. Global Osteoarthritis Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Million)
  • TABLE 3. Global Osteoarthritis Therapeutics Market estimates & forecasts by Anatomy 2019-2029 (USD Million)
  • TABLE 4. Global Osteoarthritis Therapeutics Market estimates & forecasts by Drug Type 2019-2029 (USD Million)
  • TABLE 5. Global Osteoarthritis Therapeutics Market estimates & forecasts by Distribution Channel 2019-2029 (USD Million)
  • TABLE 6. Global Osteoarthritis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 7. Global Osteoarthritis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 8. Global Osteoarthritis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 9. Global Osteoarthritis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 10. Global Osteoarthritis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 11. Global Osteoarthritis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 12. Global Osteoarthritis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 13. Global Osteoarthritis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 14. Global Osteoarthritis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 15. Global Osteoarthritis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 16. U.S. Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 17. U.S. Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 18. U.S. Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 19. Canada Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 20. Canada Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 21. Canada Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 22. UK Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 23. UK Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 24. UK Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 25. Germany Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 26. Germany Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 27. Germany Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 28. France Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 29. France Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 30. France Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 31. Italy Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 32. Italy Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 33. Italy Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 34. Spain Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 35. Spain Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 36. Spain Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 37. RoE Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 38. RoE Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 39. RoE Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 40. China Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 41. China Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 42. China Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 43. India Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 44. India Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 45. India Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 46. Japan Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 47. Japan Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 48. Japan Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 49. South Korea Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 50. South Korea Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 51. South Korea Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 52. Australia Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 53. Australia Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 54. Australia Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 55. RoAPAC Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 56. RoAPAC Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 57. RoAPAC Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 58. Brazil Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 59. Brazil Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 60. Brazil Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 61. Mexico Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 62. Mexico Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 63. Mexico Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 64. RoLA Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 65. RoLA Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 66. RoLA Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 67. Row Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 68. Row Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 69. Row Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 70. List of secondary sources, used in the study of global Osteoarthritis Therapeutics Market
  • TABLE 71. List of primary sources, used in the study of global Osteoarthritis Therapeutics Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Osteoarthritis Therapeutics Market, research methodology
  • FIG 2. Global Osteoarthritis Therapeutics Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Osteoarthritis Therapeutics Market, key trends 2021
  • FIG 5. Global Osteoarthritis Therapeutics Market, growth prospects 2022-2029
  • FIG 6. Global Osteoarthritis Therapeutics Market, porters 5 force model
  • FIG 7. Global Osteoarthritis Therapeutics Market, pest analysis
  • FIG 8. Global Osteoarthritis Therapeutics Market, value chain analysis
  • FIG 9. Global Osteoarthritis Therapeutics Market by segment, 2019 & 2029 (USD Million)
  • FIG 10. Global Osteoarthritis Therapeutics Market by segment, 2019 & 2029 (USD Million)
  • FIG 11. Global Osteoarthritis Therapeutics Market by segment, 2019 & 2029 (USD Million)
  • FIG 12. Global Osteoarthritis Therapeutics Market by segment, 2019 & 2029 (USD Million)
  • FIG 13. Global Osteoarthritis Therapeutics Market by segment, 2019 & 2029 (USD Million)
  • FIG 14. Global Osteoarthritis Therapeutics Market, regional snapshot 2019 & 2029
  • FIG 15. North America Osteoarthritis Therapeutics Market 2019 & 2029 (USD Million)
  • FIG 16. Europe Osteoarthritis Therapeutics Market 2019 & 2029 (USD Million)
  • FIG 17. Asia pacific Osteoarthritis Therapeutics Market 2019 & 2029 (USD Million)
  • FIG 18. Latin America Osteoarthritis Therapeutics Market 2019 & 2029 (USD Million)
  • FIG 19. Global Osteoarthritis Therapeutics Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable